Stay updated on PD-1/LAG-3/TIM-3 Combo in Advanced Malignancies Clinical Trial
Sign up to get notified when there's something new on the PD-1/LAG-3/TIM-3 Combo in Advanced Malignancies Clinical Trial page.

Latest updates to the PD-1/LAG-3/TIM-3 Combo in Advanced Malignancies Clinical Trial page
- Check5 days agoChange DetectedFooter revision label updated: added 'Revision: v3.4.3' and removed 'Revision: v3.4.2'.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedA new revision (v3.4.2) was added to the history, and the notice about government funding lapse along with the previous revision entry (v3.4.1) were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check41 days agoChange DetectedA site-wide funding/operational notice was added and the platform revision updated from v3.4.0 to v3.4.1; no changes were made to study data, records, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check48 days agoChange DetectedUI enhancements include displaying a glossary, color-coded change highlights (green for additions and red for deletions), and the latest revision label (v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check62 days agoChange DetectedAdded revision v3.3.4 to the history and removed revision v3.3.3 from the history.SummaryDifference0.1%

- Check84 days agoChange DetectedThe page history shows a new site revision (Revision: v3.3.3) and removal of HHS Vulnerability Disclosure and Revision: v3.3.2. These are site maintenance/version changes and do not modify the study details or results shown on the page.SummaryDifference0.1%

Stay in the know with updates to PD-1/LAG-3/TIM-3 Combo in Advanced Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD-1/LAG-3/TIM-3 Combo in Advanced Malignancies Clinical Trial page.